J 2025

First report from the Czech national registry of inborn errors of immunity (2012-2025)

CHOVANCOVÁ, Zita; Eva HLAVÁČKOVÁ; Roman HAKL; Tomas MILOTA; Pavlina KRALICKOVA et al.

Základní údaje

Originální název

First report from the Czech national registry of inborn errors of immunity (2012-2025)

Autoři

CHOVANCOVÁ, Zita; Eva HLAVÁČKOVÁ; Roman HAKL; Tomas MILOTA; Pavlina KRALICKOVA; Ivana MALKUSOVA; Beata HUTYROVA; Michaela SAFAROVA; Jana VYDLAKOVA; Dalibor JILEK; Jiri NOVAK; Helena SCHNEIDEROVÁ; Petra KRALOVA; Alena ZIMULOVA; Vitezslav NOVAK; Jaromir BYSTRON; Dita ZAVESKA; Vendula LATALOVA; Frantisek KOPRIVA; Milan KASL; Vladimir KRACIK; Renata FORMANKOVA; Petr SEDLACEK; Karolina VYTISKOVA; Michal SVOBODA; Hana NOVAKOVA a Jiří LITZMAN

Vydání

Frontiers in immunology, LAUSANNE, Frontiers Media S.A. 2025, 1664-3224

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.900 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00142498

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

registry report; primary immunodeficiency; inborn errors of immunity; Czech national registry; hematopoietic stem cell transplantation; immunoglobulin replacement therapy

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 6. 11. 2025 10:10, Mgr. Tereza Miškechová

Anotace

V originále

Introduction Congenital immune system defects represent an ever-growing group of diseases characterized by increased susceptibility to infections and association with autoimmune, autoinflammatory, allergic and malignant complications. Here, we provide the first comprehensive report on inborn errors of immunity (IEIs) in Czechia based on the analysis of patient data from the Czech national registry (CzNR) of IEIs.Material and methods The online platform of CzNR of IEIs was established in 2012, compiling data about epidemiology, type of diagnosis, clinical and laboratory parameters, as well as the treatment of patients diagnosed with IEIs since 1981.Results The total of 1,443 registered patients includes 697 males (48.3%) and 746 females (51.7%). The median age at diagnosis was 21.0 (0-86) years. The most represented group of patients was those with antibody deficiencies (788 patients; 54.6%). This was followed by complement deficiencies (242; 16.8%), combined immunodeficiencies with syndromic features (250; 17.3%), combined immunodeficiencies (55; 3.8%), congenital defects of phagocyte number, function, or both (31; 2.1%), autoinflammatory disorders (28; 1.9%), immune dysregulation diseases (24; 1.7%), intrinsic and innate immunity defects (21; 1.5%), primary immunodeficiency phenocopies (3; 0.2%), and bone marrow failure disorders (1; 0.1%). Common variable immunodeficiency (504; 34.9%), hereditary angioedema (222; 15.4%), and DiGeorge syndrome (182; 12.6%) were the most frequent diagnoses.Conclusion In this article, we report the epidemiology of IEIs in the Czech Republic for the first time based on the CzNR of IEIs data. The prevalence of IEIs is approximately 13.2 patients per 100000 inhabitants of the Czech Republic.